nalidixic acid has been researched along with Infection in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hendriks, WD | 1 |
| Sizoo, W | 1 |
| Löwenberg, B | 1 |
| Hagenbeek, A | 1 |
| Hoeprich, PD | 1 |
| Eykyn, SJ | 1 |
| Phillips, I | 1 |
| Stamey, TA | 1 |
| Nemoy, NJ | 1 |
| Higgins, M | 1 |
| Redin, GS | 1 |
| Kuck, NA | 1 |
| Forbes, M | 1 |
3 reviews available for nalidixic acid and Infection
| Article | Year |
|---|---|
[Bacteriologic management of patients with decreased resistance].
Topics: Agranulocytosis; Anti-Bacterial Agents; Antisepsis; Bacterial Infections; Drug Combinations; Humans; | 1984 |
New antimicrobics for the treatment of infections caused by gram-negative bacilli.
Topics: Ampicillin; Anti-Bacterial Agents; Cephaloridine; Cephalothin; Colistin; Gentamicins; Humans; Infect | 1967 |
Advances in antibiotics.
Topics: Adult; Anti-Bacterial Agents; Cephaloridine; Enterobacteriaceae Infections; Fusidic Acid; Gentamicin | 1969 |
2 other studies available for nalidixic acid and Infection
| Article | Year |
|---|---|
The clinical use of nalidixic acid. A review and some observations.
Topics: Adult; Aged; Drug Resistance, Microbial; Enterococcus faecalis; Escherichia coli; Female; Humans; In | 1969 |
2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial age. VI. Antibacterial efficacy in mice and in vitro.
Topics: Animals; Anti-Bacterial Agents; Imidazoles; Infections; Mice; Microbial Sensitivity Tests; Nalidixic | 1968 |